Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Corporate Action-Board to consider Dividend

 Pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, July 29, 2020 at 4:00 P.M. at the Registered Office of the Company for the following matters: 1. To discuss, consider and approve the Audited Financial Results of the Company for the Quarter and Year ended March 31st 2020 along with Audit Report of the Auditor thereon with Audited Balance Sheet, Profit & Loss A/c and Schedules &Notes.; 2. To recommend Dividend if any, for the Financial Year ended March 31st 2020 - subject to the approval of the Shareholders at the ensuing Annual General Meeting of the Company;
23-07-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for To Discuss, Consider And Approve The Audited Financial Results Of The Company For The Quarter And Year Ended March 31St 2020 .

 Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2020 ,inter alia, to consider and approve 1. To discuss, consider and approve the Audited Financial Results of the Company for the Quarter and Year ended March 31st 2020 along with Audit Report of the Auditor thereon with Audited Balance Sheet, P & L A/c and Schedules &Notes.; 2. To recommend Dividend if any, for the Financial Year ended March 31st 2020 - subject to the approval of the Shareholders at the ensuing AGM of the Company; 3. To discussa and approve drafts of Director's Report, Corporate Governance Report, Management Discussion & Analysis for the FY ended Mar 31st 2020 4. To discuss and approve appointment of Statutory Auditors and Secretarial Auditors for the Financial Year ended 2020-21. 5. To consider and approve reappointment of Managing Director Mr. Fredun Medhora and Whole Time Director Dr. (Mrs.) Daulat Medhora subject to approval of the shareholders at the ensuing AGM 6. To 7. To finalize Notice and Book Closure for the Annual General Meeting 8. Any other matter with the permission of the Chair
23-07-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Shareholding for the Period Ended June 30, 2020

 Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here
10-07-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; we furnish hereunder the confirmation certificate received from the SEBI Registered Share Transfer Agent viz. Purva Sharegistry (India) Pvt. Ltd. for the quarter ended June 30, 2020. Kindly take the same on your Records.
07-07-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Statement Of Investor Complaints For The Quarter Ended June 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ankita JoshiDesignation :- Company Secretary and Compliance Officer
07-07-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Please find enclosed herewith the Annual Secretarial Compliance Report of the Company for the financial year ended 31' March, 2020 pursuant to SEBI Circular CIR/CFD/CMD1//27/2019 dated 8" February, 2019. We request you to kindly take the above information on your records.
30-06-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Clarification

 With reference to the captioned subject, we would like to inform that the Company has intimated from time to time to the Bombay Stock Exchange all the events, information etc. that has an impact on the operation and performance of the Company which include all price sensitive information etc,. The Company has not withheld any information or events which, in our opinion , would have an impact on the price behavior in the scrip of the Company. Further, the Company has always endeavored to provide necessary information concerning the Company sought by the Exchange and/or as reasonably required to meet its statutory compliances. Therefore, the movement in Company's share price is basically due to market conditions and apparently market driven on which the Company neither has any control nor has any knowledge of reasons. The management of the Company is in no way connected with any such movement in price. We request you to kindly take the above information on your records.
01-06-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Declaration With Regards To Not Falling Under Large Corporate

 Ref: SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018 and BSE Circular dated April 11, 2019 Dear Sir, With reference to the captioned subject, we would like to inform that the Company is not a large corporate, as per criteria provided in clause 2.2 of said SEBI Circular for the year ended March 31, 2020.Accordingly, the initial disclosure in Annexure A to the said Circular is not applicable to the Company. We request you to kindly take the above information on your records
30-05-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Certificate Under Regulation 40(9) Of SEBI(Listing Obligations And Disclosure Requirements) Regulations,2015 For The Half Year Ended 31St March, 2020.

 In compliance to Regulation 40(9) & 40 (10) of SEBI Listing Regulations, 2015; we furnish hereunder the certificate for the half year ended March 31, 2020 of Fredun Pharmaceuticals Limited as issued by Rajendra & Co., Practising Company Secretaries.
21-05-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Compliance Certificate For The Period Ended 31St March, 2020.

 In Compliance to Regulation 7(3) of SEBI Listing Regulations, 2015; we furnish hereunder the Certificate, duly signed by the Company Secretary of Fredun Pharmaceuticals Limited and by the Compliance Officer of 'Purva Sharegistry (India) Private Ltd.' , designated Share Transfer Agent of the Company for the half year ended March 31, 2020.
18-05-2020
Next Page
Close

Let's Open Free Demat Account